Skip to main content
SP5007,725.51+0.65%DOW53,554.64+0.17%NASDAQ26,502.99+1.43%BTC$80,003.00+2.04%ETH$2,509.22+1.60%GOLD$4,661.20+0.17%OIL$83.90+2.03%
Smart Investors Daily
Sign InSign Up Free
GI

NYSE · GIKLY

Grifols, S.A.

Healthcare · Drug Manufacturers - General

$5.75

Down-$0.03 (-0.59%)

Updated Aug 27, 2026, 7:48 PM

SID Score

5.9/10

Composite research score

Smart Money

46/100

Neutral

Market cap
16.19B
P/E ratio
24.93
Dividend yield
1.53%
52-week range
— – —
Volume
1.69K
Avg. volume
9

Price performance

GIKLY price history

1M range · 0 trading sessions · Daily adjusted prices

GIKLY does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest GIKLY news

The latest Smart Investors Daily articles mentioning GIKLY.

Stock researchCompany · Overview

GIKLY research

Overview

Company profile and research snapshot.

Company profile

GRIFOLS SA S/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
GIKLY recent ratings
DateFirmRatingTarget
Jun 30, 2026ALANTRA EQUITIESStrong Buy—
Jun 29, 2026BANCO SANTANDEROutperform—
Jun 26, 2026BAADER EUROPE / ALPHAVALUEBuy—
Jun 18, 2026BESTINVER SECURITIESBuy—
Jun 9, 2026CAIXABANK BPIBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Feb 15, 2026

Is Grifols (BME:GRF) Pricing Reflect Its Long-Term Slide And DCF Upside Potential

If you are wondering whether Grifols shares offer solid value at today's price, it helps to step back and look at what the recent numbers and news are really telling you. The stock last closed at €10.95, with returns of 0.7% over 7 days, 0.6% over 30 days, a 2.2% decline year to date, a 20.6% gain over 1 year, a 22.6% decline over 3 years and a 49.1% decline over 5 years. Recent coverage of Grifols has focused on its position in the pharmaceuticals and biotech space and on how investors...

Yahoo · Feb 11, 2026

[Latest] Global Cell Therapy Raw Materials Market Size/Share Worth USD 29.3 Billion by 2035 at a 18.9% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Cell Therapy Raw Materials Market size & share revenue was valued at approximately USD 5.2 Billion in 2025 and is expected to reach USD 6.1 Billion in 2026 and is expected to reach around USD 29.3 Billion by 2035, at a CAGR of 18.9% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Thermo Fisher Scientifi

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By